Sfoglia per AUTORE
FENNELL DA
Collezione ASL Vercelli

  

Items : 8

The RON (MST1R)/MSP pathway is a potential therapeutic target in malignant pleural mesothelioma in Lung Cancer

2014
ASL Vercelli

Baird A-M; O'Byrne KJ; Easty D; Shiels L; Byrne A; Raeppel S; Soltermann A; Nonaka D; Fennell DA; Mutti L; Pass HI; Opitz I; Gray SG;

Estrogen receptor ? activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo in Oncogenesis

2013
ASL Vercelli

Manente AG; Valenti D; Pinton G; Jithesh PV; Daga A; Rossi L; Gray SG; O'Byrne KJ; Fennell DA; Vacca RA; Nilsson S; Mutti L; Moro L;

Estrogen receptor ? activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo in Oncogenesis

2013
ASL Vercelli

Manente AG; Valenti D; Pinton G; Jithesh PV; Daga A; Rossi L; Gray SG; O'Byrne KJ; Fennell DA; Vacca RA; Nilsson S; Mutti L; Moro L;

Estrogen receptor ? activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo in Oncogenesis

2013
ASL Vercelli

Manente AG; Valenti D; Pinton G; Jithesh PV; Daga A; Rossi L; Gray SG; O'Byrne KJ; Fennell DA; Vacca RA; Nilsson S; Mutti L; Moro L;

Inhibition of RON (MST1R) induces apoptosis and decreases the cellular migration and proliferation capacity of mesothelioma cells in Lung Cancer

2013
ASL Vercelli

Baird AM; O'Byrne KJ; Easty D; Soltermann A; Nonaka D; Fennell DA; Mutti L; Pass HI; Opitz I; Gray SG;

Advances in the systemic therapy of malignant pleural mesothelioma in Nature Clinical Practice Cardiovascular Medicine

2008
ASL Vercelli

Fennell DA; Gaudino G; O'Byrne KJ; Mutti L; van Meerbeeck J;

Bortezomib inhibits nuclear factor-?B-dependent survival and has potent in vivo activity in mesothelioma in Clinical Cancer Research

2007
ASL Vercelli

Sartore-Bianchi A; Gasparri F; Galvani A; Nici L; Darnowski JW; Barbone D; Fennell DA; Gaudino G; Porta C; Mutti L;

Bortezomib inhibits nuclear factor-?B-dependent survival and has potent in vivo activity in mesothelioma in Clinical Cancer Research

2007
ASL Vercelli

Sartore-Bianchi A; Gasparri F; Galvani A; Nici L; Darnowski JW; Barbone D; Fennell DA; Gaudino G; Porta C; Mutti L;